Tzield (Teplizumab): New Type 1 Diabetes Treatment for Kids
The FDA approved Tzield (teplizumab) for children 8-17 recently diagnosed with stage 3 type 1 diabetes, the first therapy to help preserve insulin production.
Our Hub Medical Articles
1
Active articles
1
Writing doctors
1
Categories
4
Total reads
Showing 1 of 1 articles